Stratrix
On the Record · Conmed

Conmed acquisitions, on the record

The businesses Conmed bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

BusinessDealWhenValue
In2Bones Global, Inc.
Word for word“This includes the acquisitions of In2Bones Global, Inc. ("In2Bones") in June 2022 and Biorez, Inc.” 10-K for 2023
acquisitionJune 2022—
Biorez, Inc.
Word for word“Net cash used in investing activities decreased to $20.0 million in 2023 compared to $249.5 million in 2022 primarily due to the $144.7 million payment for the In2Bones Acquisition and $83.0 million for the Biorez Acquisition in 2022.” 10-K for 2023
acquisition—$83.0 million
Buffalo Filter
Word for word“The Buffalo Filter acquisition complemented the CONMED portfolio of smoke removal devices, which provides the Company with the broadest portfolio of single-use and capital smoke evacuation products available in the medical device market today.” 10-K for 2023
acquisition——
As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year endedCash paid for acquisitions (net of cash acquired)Goodwill from acquisitions
2016-12-31—$136.7 million
2017-12-31—$2.2 million
2018-12-31—$0
2019-12-31—$217.5 million
2020-12-31—$0
2021-12-31$0$0
2022-12-31$227.7 million$199.2 million
2023-12-31$0$0
2024-12-31$0—

Deal filings since 2016

Read from Conmed’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-17. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.